NPGS offers a good alternative to trabeculectomy

Article

Non-penetrating glaucoma surgery (NPGS) is a safe and effective filtering procedure and could offer an alternative to trabeculectomy in patients with open angle glaucoma, according to Dr Aslan and colleagues from Ege University School of Medicine, Turkey.

Non-penetrating glaucoma surgery (NPGS) is a safe and effective filtering procedure and could offer an alternative to trabeculectomy in patients with open angle glaucoma, according to Dr Aslan and colleagues from Ege University School of Medicine, Turkey.

A total of 112 patients (124 eyes) with uncontrolled primary and secondary open angle glaucoma, were enrolled to take part in the study. The patients were divided into four treatment groups: viscocanalostomy (56 eyes), deep sclerectomy with non-absorbable T-Flux implant (33 eyes), deep sclerectomy with reticulated hyaluronic acid implant (SKGEL) (14 eyes) and deep sclerectomy with collagen implant (DSCI).

Mean intraocular pressure (IOP) decreased from 25.5±7.6 mmHg at baseline to 15.9±4.6 mmHg at six months, to 17.0±5.6 mmHg at one year, 16.7±4.1 mmHg at year three and 15.5±2.5 mmHg at year five in all patients. No significant difference in success rate was found between the various techniques.

The investigators suggest that NPGS is not only safe and effective, but may be a good alternative to trabeculectomy in patients with uncontrolled open angle glaucoma.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.